Overview

CoQ10 and D-ribose in Patients With Diastolic Heart Failure

Status:
Completed
Trial end date:
2021-03-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the clinical benefits of CoQ10 and D-ribose taken by patients who have diastolic heart failure, or heart failure with preserved ejection fraction (HFpEF).
Phase:
Phase 2
Details
Lead Sponsor:
University of Kansas Medical Center
Collaborator:
National Institute on Aging (NIA)
Treatments:
Coenzyme Q10